Search research articles
Contact Us
Filters
Showing results (611-620 of 1,289) with videos related to
Page
of 129
Sort By:
Cancer Research
|
June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy
W Plunkett, J O Liliemark, T M Adams, et al.
Oncotarget
|
May 11, 2019
PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells
Fabiola Cervantes-Gomez, Christine M Stellrecht, Mary L Ayres, et al.
Mitochondrion
|
September 22, 2016
Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53
Marcia A Ogasawara, Jinyun Liu, Helene Pelicano, et al.
Oncotarget
|
September 23, 2016
Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism
Jinyun Liu, Gang Chen, Helene Pelicano, et al.
Haematology and Blood Transfusion
|
January 1, 1979
Treatment of adult acute myeloblastic leukemia
K B McCredie, M J Keating, K A Dicke, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
March 16, 2022
The gut-brain axis: spatial relationship between spinal afferent nerves and 5-HT-containing enterochromaffin cells in mucosa of mouse colon
Kelsi N Dodds, Lee Travis, Melinda A Kyloh, et al.
Blood
|
November 19, 2011
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
Deepa Sampath, Chaomei Liu, Karthik Vasan, et al.
The Journal of Antimicrobial Chemotherapy
|
July 1, 1983
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients
V Fainstein, G P Bodey, L Elting, et al.
Leukemia & Lymphoma
|
September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine
F Di Raimondo, R Giustolisi, E Cacciola, et al.
Cancer
|
August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia
Paolo Strati, William Wierda, Jan Burger, et al.
Page
of 129
Search research articles
Search
Showing results (611-620 of 1,289) with videos related to
Sort By:
Page
of 129
Cancer Research
|
June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy
W Plunkett, J O Liliemark, T M Adams, et al.
Oncotarget
|
May 11, 2019
PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells
Fabiola Cervantes-Gomez, Christine M Stellrecht, Mary L Ayres, et al.
Mitochondrion
|
September 22, 2016
Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53
Marcia A Ogasawara, Jinyun Liu, Helene Pelicano, et al.
Oncotarget
|
September 23, 2016
Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism
Jinyun Liu, Gang Chen, Helene Pelicano, et al.
Haematology and Blood Transfusion
|
January 1, 1979
Treatment of adult acute myeloblastic leukemia
K B McCredie, M J Keating, K A Dicke, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
March 16, 2022
The gut-brain axis: spatial relationship between spinal afferent nerves and 5-HT-containing enterochromaffin cells in mucosa of mouse colon
Kelsi N Dodds, Lee Travis, Melinda A Kyloh, et al.
Blood
|
November 19, 2011
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
Deepa Sampath, Chaomei Liu, Karthik Vasan, et al.
The Journal of Antimicrobial Chemotherapy
|
July 1, 1983
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients
V Fainstein, G P Bodey, L Elting, et al.
Leukemia & Lymphoma
|
September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine
F Di Raimondo, R Giustolisi, E Cacciola, et al.
Cancer
|
August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia
Paolo Strati, William Wierda, Jan Burger, et al.
Page
of 129